Alps Advisors Inc Dr Reddys Laboratories LTD Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Alps Advisors Inc holds 6,662 shares of RDY stock, worth $94,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,662

Previous 6,962 4.31%

Holding current value

$94,600

Previous $530,000 0.19%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$75.41 - $84.21 $22,623 - $25,262	-300 Reduced 4.31%	6,662 $529,000
Q2 2024 Aug 13, 2024	BUY	$68.26 - $76.19 $10,921 - $12,190	160 Added 2.35%	6,962 $530,000
Q1 2024 May 14, 2024	SELL	$67.36 - $77.59 $100,568 - $115,841	-1,493 Reduced 18.0%	6,802 $498,000
Q4 2023 Feb 14, 2024	SELL	$64.27 - $69.9 $190,110 - $206,764	-2,958 Reduced 26.29%	8,295 $577,000
Q3 2023 Nov 14, 2023	SELL	$61.9 - $72.77 $102,877 - $120,943	-1,662 Reduced 12.87%	11,253 $752,000
Q2 2023 Aug 14, 2023	SELL	$53.34 - $63.11 $26,776 - $31,681	-502 Reduced 3.74%	12,915 $815,000
Q1 2023 May 10, 2023	BUY	$51.63 - $56.93 $171,256 - $188,836	3,317 Added 32.84%	13,417 $763,000
Q4 2022 Feb 14, 2023	BUY	$51.15 - $57.45 $516,615 - $580,245	10,100 New	10,100 $522,000
Q4 2021 Feb 09, 2022	SELL	$59.5 - $67.25 $474,334 - $536,117	-7,972 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$60.19 - $75.29 $52,967 - $66,255	880 Added 12.41%	7,972 $519,000
Q2 2021 Aug 11, 2021	SELL	$62.12 - $74.2 $34,352 - $41,032	-553 Reduced 7.23%	7,092 $521,000
Q1 2021 May 07, 2021	BUY	$57.98 - $73.08 $64,067 - $80,753	1,105 Added 16.9%	7,645 $469,000
Q4 2020 Feb 03, 2021	BUY	$62.61 - $71.29 $409,469 - $466,236	6,540 New	6,540 $466,000
Q4 2019 Feb 07, 2020	SELL	$36.66 - $41.78 $599,207 - $682,894	-16,345 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$34.82 - $39.26 $20,857 - $23,516	-599 Reduced 3.54%	16,345 $619,000
Q2 2019 Aug 07, 2019	SELL	$36.05 - $42.76 $10,274 - $12,186	-285 Reduced 1.65%	16,944 $635,000
Q1 2019 May 01, 2019	BUY	$35.77 - $40.57 $31,871 - $36,147	891 Added 5.45%	17,229 $698,000
Q4 2018 Feb 04, 2019	BUY	$31.89 - $38.44 $521,018 - $628,032	16,338 New	16,338 $616,000
Q4 2017 Feb 05, 2018	SELL	$34.15 - $37.62 $972,455 - $1.07 Million	-28,476 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$30.11 - $37.72 $857,412 - $1.07 Million	28,476	28,476 $1.02 Million

Others Institutions Holding RDY

# of Institutions

244

Shares Held

23.2M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.36B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Dr Reddys Laboratories LTD Transaction History